Harvard Bioscience Aktie
Deine Einschätzung
Harvard Bioscience Aktie
Was spricht für und gegen Harvard Bioscience in den nächsten Jahren?
Pro
Kontra
Rendite von Harvard Bioscience im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Harvard Bioscience | - | - | - | - | - | - | - |
| Simulations Plus | -0,98 % | 3,59 % | -0,98 % | -72,70 % | -34,42 % | -72,70 % | -81,47 % |
| Fonar Corp. New | 0,63 % | 0,63 % | 1,27 % | 28,00 % | 2,56 % | 8,84 % | 3,90 % |
| MicroVision Inc | -1,98 % | -0,67 % | -19,50 % | -50,65 % | -26,05 % | -77,51 % | -95,81 % |
Kommentare
News
Federal Reserve Chairman Jerome Powell Just Delivered Fantastic News for Stock Market Investors
Ongoing geopolitical tensions in the Middle East have triggered a surge in oil prices, stoking fears of an inflation spike that could derail the U.S. economy. The last time inflation suddenly
Better Buy: Bitcoin vs. Ethereum
With Bitcoin (CRYPTO: BTC) down 47% from its all-time high of $126,000 just a few months ago, it's perhaps no surprise that crypto investors are starting to look elsewhere for opportunities.
For
Harvard University's Investment Manager Loads Up On 3.87M ETHA Shares
According to a SEC filing dated Feb. 13, 2026, Harvard Management Co. Inc. established a new position in the iShares Ethereum Trust ETF (NASDAQ:ETHA), acquiring 3,870,900 shares. The estimated




